HROW

Harrow Health Inc (HROW)

US
$ 42.446.9%

Price Chart

Key Statistics

Market Cap
$ 966.3M
P/E Ratio
0.00
Revenue (TTM)
$ 212.86M
Volume
585.84K
52W High
$ 59.23
52W Low
$ 16.71
Dividend Yield
0.00%
Beta
0.41

Technicals

50-Day MA
25.5194
200-Day MA
35.5917
52 Week High
59.23
52 Week Low
16.71

About HROW

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Employees
382
Headquarters
Nashville, TN
CEO
Mr. Mark L. Baum J.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg